• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 RNA 和 DNA 感应途径触发病毒模拟,抑制 EZH2 靶点治疗非典型畸胎样横纹肌样瘤。

Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways.

机构信息

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

The First Affiliated Hospital of University of South China, Hengyang, Hunan, China.

出版信息

Nat Commun. 2024 Oct 29;15(1):9321. doi: 10.1038/s41467-024-53515-8.

DOI:10.1038/s41467-024-53515-8
PMID:39472584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11522499/
Abstract

Inactivating mutations in SMARCB1 confer an oncogenic dependency on EZH2 in atypical teratoid rhabdoid tumors (ATRTs), but the underlying mechanism has not been fully elucidated. We found that the sensitivity of ATRTs to EZH2 inhibition (EZH2i) is associated with the viral mimicry response. Unlike other epigenetic therapies targeting transcriptional repressors, EZH2i-induced viral mimicry is not triggered by cryptic transcription of endogenous retroelements, but rather mediated by increased expression of genes enriched for intronic inverted-repeat Alu (IR-Alu) elements. Interestingly, interferon-stimulated genes (ISGs) are highly enriched for dsRNA-forming intronic IR-Alu elements, suggesting a feedforward loop whereby these activated ISGs may reinforce dsRNA formation and viral mimicry. EZH2i also upregulates the expression of full-length LINE-1s, leading to genomic instability and cGAS/STING signaling in a process dependent on reverse transcriptase activity. Co-depletion of dsRNA sensing and cytoplasmic DNA sensing completely rescues the viral mimicry response to EZH2i in SMARCB1-deficient tumors.

摘要

SMARCB1 中的失活突变赋予了非典型畸胎样横纹肌样肿瘤(ATRT)对 EZH2 的致癌依赖性,但潜在的机制尚未完全阐明。我们发现,ATRT 对 EZH2 抑制剂(EZH2i)的敏感性与病毒模拟反应有关。与其他针对转录抑制剂的表观遗传治疗不同,EZH2i 诱导的病毒模拟不是由内源性逆转录元件的隐匿转录触发的,而是由富含内含子反转录 Alu(IR-Alu)元件的基因表达增加介导的。有趣的是,干扰素刺激基因(ISGs)富含形成 dsRNA 的内含子 IR-Alu 元件,这表明存在正反馈回路,其中这些激活的 ISGs 可能增强 dsRNA 的形成和病毒模拟。EZH2i 还上调全长 LINE-1 的表达,导致基因组不稳定性和 cGAS/STING 信号传导,这一过程依赖于逆转录酶活性。dsRNA 感应和细胞质 DNA 感应的共同耗竭完全挽救了 SMARCB1 缺陷肿瘤对 EZH2i 的病毒模拟反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/d654563a4c27/41467_2024_53515_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/9faa8279afb1/41467_2024_53515_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/e76ffd2c4b51/41467_2024_53515_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/3e08e8ec3cee/41467_2024_53515_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/694584fcb26c/41467_2024_53515_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/ea7753b50872/41467_2024_53515_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/d654563a4c27/41467_2024_53515_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/9faa8279afb1/41467_2024_53515_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/e76ffd2c4b51/41467_2024_53515_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/3e08e8ec3cee/41467_2024_53515_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/694584fcb26c/41467_2024_53515_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/ea7753b50872/41467_2024_53515_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbea/11522499/d654563a4c27/41467_2024_53515_Fig6_HTML.jpg

相似文献

1
Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways.通过 RNA 和 DNA 感应途径触发病毒模拟,抑制 EZH2 靶点治疗非典型畸胎样横纹肌样瘤。
Nat Commun. 2024 Oct 29;15(1):9321. doi: 10.1038/s41467-024-53515-8.
2
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.表观遗传学治疗诱导反转 SINEs 的转录和 ADAR1 的依赖性。
Nature. 2020 Dec;588(7836):169-173. doi: 10.1038/s41586-020-2844-1. Epub 2020 Oct 21.
3
RNA sensing induced by chromosome missegregation augments anti-tumor immunity.染色体错分离诱导的RNA传感增强抗肿瘤免疫。
Mol Cell. 2025 Feb 20;85(4):770-786.e7. doi: 10.1016/j.molcel.2024.11.025. Epub 2024 Dec 19.
4
Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.针对 CBP/p300 这一对 PAR 蛋白依赖性,克服 SMARCB1 缺失型癌症中 KREMEN2 的去抑制作用。
Nat Commun. 2024 Jun 5;15(1):4770. doi: 10.1038/s41467-024-49063-w.
5
Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.抑制核输出可恢复分子亚型的非典型畸胎瘤/横纹肌样瘤中截断的 SMARCB1/INI1 蛋白的核定位和残留肿瘤抑制功能。
Acta Neuropathol. 2021 Aug;142(2):361-374. doi: 10.1007/s00401-021-02328-w. Epub 2021 May 18.
6
SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors.SMAD依赖的信号传导在SMARCB1缺陷的果蝇模型及非典型畸胎样/横纹肌样肿瘤的生物学中起有害作用。
J Neurooncol. 2017 Feb;131(3):477-484. doi: 10.1007/s11060-016-2326-3. Epub 2017 Jan 20.
7
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.具有 SMARCA4 突变的非典型畸胎样/横纹肌样肿瘤(ATRTs)在分子上与 SMARCB1 缺失病例不同。
Acta Neuropathol. 2021 Feb;141(2):291-301. doi: 10.1007/s00401-020-02250-7. Epub 2020 Dec 17.
8
Oncogenic roles of SMARCB1/INI1 and its deficient tumors.SMARCB1/INI1的致癌作用及其缺陷型肿瘤
Cancer Sci. 2017 Apr;108(4):547-552. doi: 10.1111/cas.13173. Epub 2017 Apr 12.
9
Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.22号环状染色体患者非典型畸胎样横纹肌样瘤的一种新致癌机制描述
Am J Med Genet A. 2017 Jan;173(1):245-249. doi: 10.1002/ajmg.a.37993. Epub 2016 Oct 12.
10
SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.SMARCB1 缺失通过上调非典型畸胎样横纹肌样肿瘤中的 MIR17HG 诱导可药物治疗的 cyclin D1 缺乏。
J Pathol. 2020 Sep;252(1):77-87. doi: 10.1002/path.5493. Epub 2020 Aug 1.

引用本文的文献

1
SMARCB1-related schwannomatosis and other SMARCB1-associated phenotypes: clinical spectrum and molecular pathogenesis.与SMARCB1相关的神经鞘瘤病及其他与SMARCB1相关的表型:临床谱与分子发病机制
Fam Cancer. 2025 Aug 12;24(3):64. doi: 10.1007/s10689-025-00486-4.
2
Aberrant histone modifications in pediatric brain tumors.小儿脑肿瘤中的异常组蛋白修饰
Front Oncol. 2025 Jun 10;15:1587157. doi: 10.3389/fonc.2025.1587157. eCollection 2025.
3
Intrathoracic Rhabdoid Tumor: A Rare Site in a Jordanian Infant.胸腔横纹肌肉瘤:约旦一名婴儿的罕见发病部位。

本文引用的文献

1
Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular Homeostasis.内源性逆转录元件与癌症治疗和细胞内稳态中的病毒模拟反应。
Cancer Discov. 2021 Nov;11(11):2707-2725. doi: 10.1158/2159-8290.CD-21-0506. Epub 2021 Oct 14.
2
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.EZH2抑制激活了一条双链RNA-STING-干扰素应激轴,该轴增强了前列腺癌对PD-1检查点阻断的反应。
Nat Cancer. 2021 Apr;2(4):444-456. doi: 10.1038/s43018-021-00185-w. Epub 2021 Mar 22.
3
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.
Cureus. 2025 Mar 13;17(3):e80520. doi: 10.7759/cureus.80520. eCollection 2025 Mar.
4
Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy.探索病毒模拟与表观遗传学及肿瘤免疫的结合:癌症治疗的新视角。
Int J Biol Sci. 2025 Jan 6;21(3):958-973. doi: 10.7150/ijbs.103877. eCollection 2025.
表观遗传学治疗诱导反转 SINEs 的转录和 ADAR1 的依赖性。
Nature. 2020 Dec;588(7836):169-173. doi: 10.1038/s41586-020-2844-1. Epub 2020 Oct 21.
4
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.Tazemetostat 治疗 INI1/SMARCB1 缺失的晚期上皮样肉瘤:一项国际、开放标签、2 期篮子研究。
Lancet Oncol. 2020 Nov;21(11):1423-1432. doi: 10.1016/S1470-2045(20)30451-4. Epub 2020 Oct 6.
5
Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer.化疗耐药乳腺癌中诱导病毒模拟的表观遗传开关逃避
Cancer Discov. 2020 Sep;10(9):1312-1329. doi: 10.1158/2159-8290.CD-19-1493. Epub 2020 Jun 16.
6
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition.全基因组泛癌症分析鉴定了由 LINE-1 反转录转座促进的驱动重排。
Nat Genet. 2020 Mar;52(3):306-319. doi: 10.1038/s41588-019-0562-0. Epub 2020 Feb 5.
7
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors.克隆扩增的 T 细胞揭示横纹肌瘤的免疫原性。
Cancer Cell. 2019 Dec 9;36(6):597-612.e8. doi: 10.1016/j.ccell.2019.10.008. Epub 2019 Nov 7.
8
Synthesis and Characterization of Specific Reverse Transcriptase Inhibitors for Mammalian LINE-1 Retrotransposons.合成和鉴定哺乳动物 LINE-1 反转录转座子的特异性逆转录酶抑制剂。
Cell Chem Biol. 2019 Aug 15;26(8):1095-1109.e14. doi: 10.1016/j.chembiol.2019.04.010. Epub 2019 May 30.
9
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update).g:Profiler:一个用于功能富集分析和基因列表转换的网络服务器(2019 更新)。
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198. doi: 10.1093/nar/gkz369.
10
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss.肿瘤源性 IFN 触发慢性途径激动和对 ADAR 缺失的敏感性。
Nat Med. 2019 Jan;25(1):95-102. doi: 10.1038/s41591-018-0302-5. Epub 2018 Dec 17.